Hypericum Nature's Bounty

Hypericum perforatum, the active ingredient in Hypericum Nature's Bounty, is a herbal antidepressant presented as a dry extract for oral use. It is employed to manage mild to moderate depression, seasonal affective disorder and anxiety in adult patients.

GNH USA supplies Hypericum Nature's Bounty as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Products are manufactured under GMP conditions and are available for bulk and retail orders.

Hypericum perforatum acts as an herbal antidepressant influencing neurotransmitter pathways linked to mood regulation.

Mild to moderate depression: helps alleviate depressive symptoms in adults. Seasonal affective disorder: reduces mood disturbances associated with seasonal changes. Anxiety: may lessen anxiety symptoms in individuals with mild anxiety.

Hypericum perforatum may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, stomach cramps or diarrhea. - Photosensitivity: increased skin sensitivity to sunlight. - Dizziness or light‑headedness. - Fatigue or headache.

Serious or Rare Side Effects: - Serotonin syndrome: risk when combined with other serotonergic agents. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

When considering Hypericum perforatum, several safety measures should be observed.

- Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown safety; consider alternative therapies. - Drug interactions: review concomitant serotonergic medications before use. - Photosensitivity: advise patients to limit sun exposure and use protection. - Psychiatric monitoring: observe for mood swings or activation of mania. Store at ambient temperature: keep in original container, protect from moisture and light.

Hypericum perforatum can affect the pharmacokinetics and pharmacodynamics of several medicines.

Major Interactions (Avoid): - SSRIs (e.g., fluoxetine, sertraline): risk of serotonin syndrome. - MAO inhibitors (e.g., phenelzine): heightened serotonergic activity. - Tricyclic antidepressants (e.g., amitriptyline): increased toxicity risk. - Anticoagulants (e.g., warfarin): reduced anticoagulant effect, increased bleeding risk. - Oral contraceptives: decreased plasma levels, possible contraceptive failure.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., phenytoin): reduced serum concentrations. - Digoxin: possible decrease in drug levels. - Cyclosporine: lowered exposure, risk of organ rejection.